About Us

OUR 

VALUES

Frame 1171274880.png__PID:ffd5dd3a-a398-4468-8174-88429356b136

People

The CAPNOS mission is to help one million people quit vaping by 2027. We focus on the unique need for oral fixation cravings and stress relief alternatives to deliver a satisfying experience for anyone, anytime, anywhere.

Frame 1171274880 (1).png__PID:c51b6d00-a679-47d6-9a7a-f210b0a678db

Product

We specialize in producing affordable, accessible behavioral aids that can be used by youth and adults. Our products are not vapes, nor tobacco products, as only air is inhaled, yet can be used for quitting, stimming, or relief.

Frame 1171274880 (2).png__PID:6d00a679-27d6-4a7a-b210-b0a678db3b6f

Planet

Our products are made to last, saving you money and reducing waste from offsetting the use of disposable products. We aim to help people live healthier lives, with a cleaner planet too.


Timeline

V2 Timeline Desktop-2.png__PID:6d55a870-884f-4567-81a7-7577d41a7e40
Timeline v2-2.png__PID:ae1356b2-4f89-4821-8eb1-0ff27e7d68ff


Our Impact

CAPNOS has delivered over 80,000 devices in the first three years of sales to customers in 93 countries and growing. Our team spans six continents, bringing a global perspective on a universal issue. We give back to local communities with free educational programming in schools, mentorship opportunities, and philanthropic donations supporting marginalized communities. CAPNOS is a certified LGBTQ+ and Asian-American-owned business.

Efforts to increase accessibility through retail adoption, partnerships with quit programs, and achieving operational excellency to provide lower costs with faster service is what compels us to seek constant improvement.  

Our Philosophy

Over one billion people smoke cigarettes globally. This habit is the leading cause for millions of preventable deaths yearly. Vaping was then positioned as a tool to reduce or quit smoking, having brought new pros and cons toward public health efforts. What then, could be used to help people quit vaping?

CAPNOS aims to educate and increase research interest in the field of sensory dependencies, as our devices are flavored, pressurized air inhalers for use as behavioral aids. We understand that the root craving often extends beyond nicotine, as shown by our CAPNOS Vaping Study Survey, published July 2024. 

Many people depend on vaping or smoking as a coping mechanism for stress or anxiety, to which an addiction often develops. We aim to further assess the efficacy of which CAPNOS devices can suppport habit reduction, replacement, or elimination efforts with vapes, through grant-funded research opportunities. Regulatory advocacy efforts are ongoing as we define a new product category that is neither a tobacco, nicotine, medical, or food item.

Academic research through laboratory studies are ongoing; we embrace challenging the status quo.

MEET 

OUR 

TEAM

MEET

OUR 

TEAM

Brendan.png__PID:4119e005-c4af-4907-b112-593366455e44

Brendan Wang

Founder and CEO

Edin Mucic.png__PID:4907f112-5933-4645-9e44-80617fdb51e7

Edin Mucic

Brand Development Specialist

Pierre.png__PID:c4af4907-f112-4933-a645-5e4480617fdb

Pierre Aguilar

Community Development Specialist

Loretta Imonikhe

Human Resources and Administrative Associate

John.png__PID:e005c4af-4907-4112-9933-66455e448061

Martkim Salvador 

Customer Success Specialist

Board of 

Advisors

Kavita Gunda Bouknight

MatchHealth CEO

Eric Achtyes, MD, MS

Chair of Psychiatry, WMU School of Medicine; Behavioral Health Director 

Mike Miller, PhD.

General Partner at Liquid 2 Ventures

Omari Bouknight

Abbott DVP Structural Heart

"We 

aim 

to 

help 

ONE

 MILLION

 people 

quit 

vaping 

by 

2027."

We hit our vapes when we woke up, between meals, during school or work, while driving, and realized we just craved a hit to satisfy an oral fixation. In this video, Founder and CEO Brendan Wang recounts why CAPNOS was created, along with a brief history of the team's impact, and the direction the team is headed toward. 

Vaping became expensive and we no longer wanted to sacrifice our health, especially as our only nicotine buzz came from the first hit of the day. Can you relate?

Disclaimers:

There are currently no studies on the efficacy of these products for smoking or vaping cessation, as the FDA has not approved any of them for that purpose. These statements have not been evaluated by the FDA and are not meant to treat, diagnose, or prevent any disease or illness. All Starter Packs can be used with or without flavors. If you are allergic or sensitive to essential oils or natural extracts, please do not use the included flavors as to prevent contact dermatitis.